Abstract
Poster 51: Health-related Outcomes Associated With Tapentadol Extended Release and Oxycodone Controlled Release Treatment for Chronic Low Back or Osteoarthritis Pain: Results of a Randomized, Open-label, Phase 3 Long-term Safety Trial
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
